Hims & Hers Health (NYSE:HIMS) Shares Gap Down – Time to Sell?

Hims & Hers Health, Inc. (NYSE:HIMS) gapped down before the market opened on Friday . The stock had previously closed at $25.73, but opened at $24.15. Hims & Hers Health shares last traded at $25.01, with a volume of 2,507,628 shares.

Analyst Ratings Changes

Several analysts have commented on the stock. Bank of America cut shares of Hims & Hers Health from a “buy” rating to an “underperform” rating and lowered their target price for the stock from $32.00 to $18.00 in a research note on Thursday, November 14th. Deutsche Bank Aktiengesellschaft increased their target price on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research report on Wednesday, November 6th. Morgan Stanley began coverage on Hims & Hers Health in a report on Tuesday, December 17th. They issued an “overweight” rating and a $42.00 price target for the company. BTIG Research began coverage on shares of Hims & Hers Health in a research note on Tuesday. They set a “buy” rating and a $35.00 price objective for the company. Finally, Piper Sandler raised their target price on shares of Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a research report on Monday. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $25.13.

Hims & Hers Health Trading Down 4.2 %

The business’s 50-day simple moving average is $27.11 and its two-hundred day simple moving average is $21.62. The company has a market capitalization of $5.39 billion, a PE ratio of 56.02 and a beta of 1.31.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.26. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The firm had revenue of $401.56 million during the quarter, compared to the consensus estimate of $382.20 million. During the same quarter in the prior year, the business posted ($0.04) earnings per share. Hims & Hers Health’s revenue for the quarter was up 77.1% on a year-over-year basis. On average, analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Insider Activity

In other news, insider Soleil Boughton sold 268,932 shares of the firm’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $27.75, for a total transaction of $7,462,863.00. Following the transaction, the insider now directly owns 169,803 shares of the company’s stock, valued at approximately $4,712,033.25. This trade represents a 61.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Oluyemi Okupe sold 269,739 shares of the stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $20.31, for a total transaction of $5,478,399.09. Following the completion of the transaction, the chief financial officer now owns 145,763 shares of the company’s stock, valued at $2,960,446.53. This represents a 64.92 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 1,333,446 shares of company stock valued at $34,175,197. Company insiders own 17.71% of the company’s stock.

Institutional Investors Weigh In On Hims & Hers Health

A number of institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in shares of Hims & Hers Health by 2,173.7% in the 4th quarter. GAMMA Investing LLC now owns 2,251 shares of the company’s stock worth $54,000 after purchasing an additional 2,152 shares during the last quarter. Quest Partners LLC boosted its holdings in Hims & Hers Health by 5,944.1% during the second quarter. Quest Partners LLC now owns 3,566 shares of the company’s stock worth $72,000 after buying an additional 3,507 shares in the last quarter. CWM LLC grew its position in Hims & Hers Health by 21.4% in the third quarter. CWM LLC now owns 5,982 shares of the company’s stock worth $110,000 after buying an additional 1,054 shares during the last quarter. Quarry LP increased its holdings in shares of Hims & Hers Health by 91.0% in the third quarter. Quarry LP now owns 6,113 shares of the company’s stock valued at $113,000 after buying an additional 2,913 shares in the last quarter. Finally, Amalgamated Bank lifted its position in shares of Hims & Hers Health by 55.9% during the 2nd quarter. Amalgamated Bank now owns 6,566 shares of the company’s stock valued at $133,000 after acquiring an additional 2,354 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors and hedge funds.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.